Dr. Chunhua Xiao 肖春花
Chief Physician
Department of Breast Oncology I, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radical mastectomy for breast cancer and breast reconstruction surgery.
Dr. Xiao is a Chief Physician and master’s supervisor at Tianjin Medical University Cancer Institute & Hospital. A member of the Jiusan Society Tianjin Branch, Dr. Xiao focuses on standardized and individualized breast cancer treatment, including multidisciplinary consultations. In 2010–2011, Dr. Xiao performed three public remote surgical demonstrations at a national breast reconstruction workshop.
Professional roles
- Member, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Xiao Chunhua). Papers usually list the name as Chunhua Xiao or Xiao C.
Selected publications
13 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Curr Oncol, 2023 (senior author): A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study. PubMed 38248093
- Aesthetic Plast Surg, 2023 (senior author): Transaxillary Single-Port Endoscopic Nipple-Sparing Mastectomy with Immediate Implant-based Breast Reconstruction in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy or Not: A Comparative Study with Analysis of Surgical Complications and Patient-Reported Outcomes. PubMed 37700196
- Front Oncol, 2023 (senior author): Trans-axillary single port insufflation technique-assisted endoscopic surgery for breast diseases: Clinic experience, cosmetic outcome and oncologic result. PubMed 37064139
- Cancer Control, 2022 (senior author): An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A Lesions. PubMed 37735939
- Breast Cancer Res Treat, 2019 (senior author): KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients. PubMed 30535933
- Oncol Lett, 2017 (senior author): Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery. PubMed 28693138
- Tumour Biol, 2013 (senior author): The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients. PubMed 23296702
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion